Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yang, Lin ^a,c   Li, Jingguang ^a   Lai, Jianqiang ^b   Luan, Hemi ^c   Cai, Zongwei ^a   Wang, Yibaina ^a   Zhao, Yunfeng ^a   Wu, Yongning ^a  

^a CHINA NATIONAL CENTER FOR FOOD SAFETY RISK ASSESSMENT   (China)

^b Chinese Centre for Disease Control and Prevention   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DECANOIC ACID DERIVATIVE; FLUOROCARBON; LIOTHYRONINE; OCTANOIC ACID DERIVATIVE; PERFLUORODECANOIC ACID; PERFLUOROOCTANOIC ACID; POLLUTANT; THYROTROPIN; THYROXINE;

ADULT; BLOOD; CHEMISTRY; CHINA; DIAGNOSIS; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS BLOOD; HUMAN; MALE; POLLUTANT; PREGNANCY; PRENATAL EXPOSURE;

ADULT; BEIJING; CAPRYLATES; DECANOIC ACIDS; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL BLOOD; FETUS; FLUOROCARBONS; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84959420642     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21699     Document Type: Article

References (67)

1. Kissa, E. Fluorinated surfactants and repellents. 2nd edn Marcel Decker, New York, (NY 2001).
2. Fromme, H., Tittlemier, S. A., Volkel, W., Wilhelm, M., Twardella, D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health. 212, 239-270 (2009).
3. Vestergren, R., Cousins, I. T. Tracking the pathways of human exposure to perfluorocarboxylates. Environ. Sci. Technol. 43, 5565-5575 (2009).
4. Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A., Needham, L. L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 115, 1596-1602 (2007).
5. Toms, L. M. et al. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011. Environ. Int. 71, 74-80 (2014).
6. Liu, J., Li, J., Luan, Y., Zhao, Y., Wu, Y. Geographical distribution of perfluorinated compounds in human blood from Liaoning province, China. Environ. Sci. Technol. 43, 4044-4048 (2009).
7. Glynn, A. et al. Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ. Sci. Technol. 46, 9071-9079 (2012).
8. Yeung, L. W., Robinson, S. J., Koschorreck, J., Mabury, S. A. Part II. A temporal study of PFOS and its precursors in human plasma from two German cities in 1982-2009. Environ. Sci. Technol. 47, 3875-3882 (2013).
9. Yeung, L. W., Robinson, S. J., Koschorreck, J., Mabury, S. A., Part I. A temporal study of PFCAs and their precursors in human plasma from two German cities 1982-2009. Environ. Sci. Technol. 47, 3865-3874 (2013).
10. Houde, M., Martin, J. W., Letcher, R. J., Solomon, K. R., Muir, D. C. Biological monitoring of polyfluoroalkyl substances: A review. Environ. Sci. Technol. 40, 3463-3473 (2006).
11. Kato, K., Wong, L. Y., Jia, L. T., Kuklenyik, Z., Calafat, A. M. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ. Sci. Technol. 45, 8037-8045 (2011).
12. Stockholm Convention on persistent organic pollutants (POPs). 2009. Available at: http://chm.pops.int/Convention/Media/Pressreleases/COP4Geneva9May2009/tabid/542/lan guage/en-US/Default.aspx. (Accessed: 30th July 2015).
13. Wang, T. et al. Perfluorinated compounds in surface waters from Northern China: comparison to level of industrialization. Environ. Int. 42, 37-46 (2012).
14. Wang, T., Wang, Y., Liao, C., Cai, Y., Jiang, G. Perspectives on the inclusion of perfluorooctane sulfonate into the Stockholm Convention on Persistent Organic Pollutants. Environ. Sci. Technol. 43, 5171-5175 (2009).
15. Li, L., Zhai, Z., Liu, J., Hu, J. Estimating industrial and domestic environmental releases of perfluorooctanoic acid and its salts in China from 2004 to 2012. Chemosphere. 129, 100-109 (2015).
16. Chang, S. C. et al. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology. 243, 330-339 (2008).
17. Martin, M. T. et al. Toxicogenomic study of triazole fungicides and perfluoroalkyl acids in rat livers predicts toxicity and categorizes chemicals based on mechanisms of toxicity. Toxicol. Sci. 97, 595-613 (2007).
18. Yu, W.-G., Liu, W., Jin, Y.-H. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ. Toxicol. Chem. 28, 990-996 (2009).
19. Curran, I. et al. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). J. Toxicol. Environ. Health. A. 71, 1526-1541 (2008).
20. Thibodeaux, J. R. et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 74, 369-381 (2003).
21. Luebker, D. J., York, R. G., Hansen, K. J., Moore, J. A., Butenhoff, J. L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology. 215, 149-169 (2005).
22. Lau, C. et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol. Sci. 74, 382-392 (2003).
23. Yu, W.-G. et al. Prenatal and Postnatal Impact of Perfluorooctane Sulfonate (PFOS) on Rat Development: A Cross-Foster Study on Chemical Burden and Thyroid Hormone System. Environ. Sci. Technol. 43, 8416-8422 (2009).
24. Seacat, A. M., Thomford, P. J., Hansen, K. J., Olsen, G. W., Case, M. T., Butenhoff, J. L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68, 249-264 (2002).
25. Butenhoff, J. et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol. Sci. 69, 244-257 (2002).
26. Melzer, D., Rice, N., Depledge, M. H., Henley, W. E., Galloway, T. S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ. Health Perspect. 118, 686-692 (2010).
27. Lopez-Espinosa, M. J., Mondal, D., Armstrong, B., Bloom, M. S., Fletcher, T. Thyroid function and perfluoroalkyl acids in children living near a chemical plant. Environ. Health Perspect. 120, 1036-1041 (2012).
28. Winquist, A., Steenland, K. Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts. Epidemiology. 25, 255-264 (2014).
29. C8 Science Panel. Probable Link Evaluation of Thyroid disease. (30 July 2012). Available at: http://www.c8sciencepanel.org/prob-link. html. (Accessed: 30th July 2015).
30. Dallaire, R., Dewailly, E., Pereg, D., Dery, S., Ayotte, P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ. Health Perspect. 117, 1380-1386 (2009).
31. Ji, K. et al. Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ. Int. 45, 78-85 (2012).
32. Shrestha, S. et al. Perfluoroalkyl substances and thyroid function in older adults. Environ. Int. 75, 206-214 (2015).
33. Jain, R. B. Association between thyroid profile and perfluoroalkyl acids: data from NHNAES 2007-2008. Environ. Res. 126, 51-59 (2013).
34. Wen, L. L., Lin, L. Y., Su, T. C., Chen, P. C., Lin, C. Y. Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007-2010. J. Clin. Endocrinol. Metab. 98, E1456-1464 (2013).
35. Knox, S. S., Jackson, T., Frisbee, S. J., Javins, B., Ducatman, A. M. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J. Toxicol. Sci. 36, 403-410 (2011).
36. Lewis, R. C., Johns, L. E., Meeker, J. D. Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011-2012. Int. J. Environ. Res. Public. Health. 12, 6098-6114 (2015).
37. Emmett, E. A. et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J. Occup. Environ. Med. 48, 771-779 (2006).
38. Bloom, M. S., Kannan, K., Spliethoff, H. M., Tao, L., Aldous, K. M., Vena, J. E. Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol. Behav. 99, 240-245 (2010).
39. Chan, E., Burstyn, I., Cherry, N., Bamforth, F., Martin, J. W. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ. Res. 111, 559-564 (2011).
40. Kim, S. et al. Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ. Sci. Technol. 45, 7465-7472 (2011).
41. Wang, Y. et al. Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a crosssectional study. Environ. Health. 12, 76-82 (2013).
42. Wang, Y. et al. Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ. Health Perspect. 122, 529-534 (2014).
43. Webster, G. M., Venners, S. A., Mattman, A., Martin, J. W. Associations between perfluoroalkyl acids (PFASs) and maternal thyroid hormones in early pregnancy: a population-based cohort study. Environ. Res. 133, 338-347 (2014).
44. Berg, V. et al. Assessing the relationship between perfluoroalkyl substances, thyroid hormones and binding proteins in pregnant women; a longitudinal mixed effects approach. Environ. Int. 77, 63-69 (2015).
45. Preau, L., Fini, J. B., Morvan-Dubois, G., Demeneix, B. Thyroid hormone signaling during early neurogenesis and its significance as a vulnerable window for endocrine disruption. Biochim. Biophys. Acta. 1849, 112-121 (2015).
46. Idris, I., Srinivasan, R., Simm, A., Page, R. C. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin. Endocrinol. 63, 560-565 (2005).
47. Morreale de Escobar, G., Obregon, M. J., Escobar del Rey, F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia ? J. Clin. Endocrinol. Metab. 85, 3975-3987 (2000).
48. Morreale de Escobar, G., Obregon M. J., Escobar del Rey F. Role of thyroid hormone during early brain development. Eur. J. Endocrinol. 151 Suppl 3, U25-37 (2004).
49. Wang, Y. et al. Prenatal Exposure to Perfluroalkyl Substances and Children's IQ: The Taiwan Maternal and Infant Cohort Study. J. Hyg. Environ. Health. 218, 639-644 (2015).
50. Liu, J. et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ. Int. 37, 1206-1212 (2011).
51. Berg, V. et al. Maternal serum concentrations of per-and polyfluoroalkyl substances and their predictors in years with reduced production and use. Environ. Int. 69, 58-66 (2014).
52. Jensen, T. K., Andersen, L. B., Kyhl, H. B., Nielsen, F., Christesen, H. T., Grandjean, P. Association between perfluorinated compound exposure and miscarriage in Danish pregnant women. PloS one. 10, e0123496. Doi: 10.1371/journal.pone.0123496 (2015).
53. Kato, K. et al. Changes in serum concentrations of maternal poly-and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006. Environ. Sci. Technol. 48, 9600-9608 (2014).
54. Yu, W. G., Liu, W., Liu, L., Jin, Y. H. Perfluorooctane sulfonate increased hepatic expression of OAPT2 and MRP2 in rats. Arch. Toxicol. 85, 613-621 (2011).
55. Gorrochategui, E., Perez-Albaladejo, E., Casas, J., Lacorte, S., Porte, C. Perfluorinated chemicals: differential toxicity, inhibition of aromatase activity and alteration of cellular lipids in human placental cells. Toxicol. Appl. Pharmacol. 277, 124-130 (2014).
56. Kleszczynski, K., Gardzielewski, P., Mulkiewicz, E., Stepnowski, P., Skladanowski, A. C. Analysis of structure-cytotoxicity in vitro relationship (SAR) for perfluorinated carboxylic acids. Toxicol. In Vitro. 21, 1206-1211 (2007).
57. Liu, W., Chen, S., Quan, X., Jin, Y. H. Toxic effect of serial perfluorosulfonic and perfluorocarboxylic acids on the membrane system of a freshwater alga measured by flow cytometry. Environ. Toxicol. Chem. 27, 1597-1604 (2008).
58. Ramazani Tehrani, F., Aghaee, M., Asefzadeh, S. The comparison of thyroid function tests in cord blood following cesarean section of vaginal delivery. Int. J. Endocrinol. Metab. 1, 22-26 (2003).
59. Hume, R. et al. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J. Clin. Endocrinol. Metab. 89, 4097-4103 (2004).
60. Fisher, D. A. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin. Obstet. Gynecol. 40, 16-31 (1997).
61. Weiss, J. M., Andersson, P. L., Lamoree, M. H., Leonards, P. E., van Leeuwen, S. P., Hamers, T. Competitive binding of poly-and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol. Sci. 109, 206-216 (2009).
62. Landers, K. A., McKinnon, B. D., Li, H., Subramaniam, V. N., Mortimer, R. H., Richard, K. Carrier-mediated thyroid hormone transport into placenta by placental transthyretin. J. Clin. Endocrinol. Metab. 94, 2610-2616 (2009).
63. Boas, M., Feldt-Rasmussen, U., Main, K. M. Thyroid effects of endocrine disrupting chemicals. Mol. Cell. Endocrinol. 2012, 355, 240-248 (2012).
64. Bloom, M. S., Jansing, R. L., Kannan, K., Rej, R., Fitzgerald, E. F. Thyroid hormones are associated with exposure to persistent organic pollutants in aging residents of upper Hudson River communities. Int. J. Hyg. Environ. Health. 217, 473-482 (2014).
65. Huang, F., Wen, S., Li, J., Zhong, Y., Zhao, Y., Wu, Y. The human body burden of polybrominated diphenyl ethers and their relationships with thyroid hormones in the general population in Northern China. Sci. Total Environ. 466-467, 609-615 (2014).
66. Hansen, K. J., Clemen, L. A., Ellefson, M. E., Johnson, H. O. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35, 766-770 (2001).
67. Hornung, R. W., Reed, L. D. Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 5, 46-51 (1990).